Royalty Pharma
In Pat Dorsey's portfolio · Dorsey Asset Management
Ticker RPRX
Still in the portfolio as of Q2 2026. Every quarter it shows up in a Dorsey Asset Management 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2026 | Add 8% | 2,456,528 | 8.8% |
| Q1 2026 | Add 1% | 2,276,570 | 8.7% |
| Q4 2025 | Reduce 4% | 2,259,469 | 7.6% |
| Q3 2025 | Buy | 2,350,449 | 7.5% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.